BIM
TXMD icon

BlackRock Investment Management’s TherapeuticsMD TXMD Stock Holding History

BlackRock Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.27M Sell
11,344
-54
-0.5% -$16.7K ﹤0.01% 1864
2016
Q3 		$3.88M Buy
11,398
+152
+1% +$55.5K ﹤0.01% 1667
2016
Q2 		$4.78M Buy
11,246
+1,264
+13% +$521K 0.01% 1466
2016
Q1 		$3.19M Buy
9,982
+1,440
+17% +$491K ﹤0.01% 1679
2015
Q4 		$4.43M Buy
8,542
+19
+0.2% +$7.01K 0.01% 1472
2015
Q3 		$2.5M Sell
8,523
-136
-2% -$48.3K ﹤0.01% 1908
2015
Q2 		$3.4M Buy
8,659
+1,740
+25% +$614K ﹤0.01% 1797
2015
Q1 		$2.09M Buy
6,919
+677
+11% +$165K ﹤0.01% 1985
2014
Q4 		$1.39M Sell
6,242
-18
-0.3% -$3.71K ﹤0.01% 2319
2014
Q3 		$1.45M Buy
6,260
+451
+8% +$114K ﹤0.01% 2240
2014
Q2 		$1.28M Buy
5,809
+1,014
+21% +$226K ﹤0.01% 2420
2014
Q1 		$1.51M Buy
4,795
+55
+1% +$17.5K ﹤0.01% 2224
2013
Q4 		$1.24M Buy
4,740
+356
+8% +$78K ﹤0.01% 2355
2013
Q3 		$642K Buy
4,384
+376
+9% +$45.5K ﹤0.01% 2755
2013
Q2 		$607K Buy
+4,008
New +$549K ﹤0.01% 2726

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Investment Management's TXMD Position: Q4 2016 in Review

BlackRock Investment Management reduced its TherapeuticsMD (TXMD) stake by 0.47% in Q4 2016, selling an estimated $16.7K and leaving 11,344 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

BlackRock Investment Management first reported a position in TXMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.78M in Q2 2016. 146 funds tracked by Wall St. Rank hold TXMD as of Q4 2016.

  • BlackRock Investment Management held 11,344 shares of TherapeuticsMD worth $3.27M as of Q4 2016.
  • BlackRock Investment Management sold 54 TherapeuticsMD shares in Q4 2016, an estimated $16.7K.
  • TherapeuticsMD made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1864 holding.
  • BlackRock Investment Management first reported a position in TherapeuticsMD in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's TherapeuticsMD position peaked at $4.78M in Q2 2016.
  • 146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.